Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Sporn

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Biochemical and Biophysical Research Communications|January 22, 2008
A dicyanotriterpenoid induces cytoprotective enzymes and reduces multiplicity of skin tumors in UV-irradiated miceAlbena T Dinkova-Kostova, Stephanie N Jenkins, Scott L Wehage, et al.
Antioxidants & Redox Signaling|July 4, 2012
Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's diseaseNavneet Ammal Kaidery, Rebecca Banerjee, Lichuan Yang, et al.
Molecular Cancer Therapeutics|January 24, 2007
Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genesMelinda S Yates, Masafumi Tauchi, Fumiki Katsuoka, et al.
Blood|January 5, 2002
Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemiaMarina Konopleva, Twee Tsao, Peter Ruvolo, et al.
Carcinogenesis|April 24, 2009
Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated miceMelinda S Yates, Quynh T Tran, Patrick M Dolan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2013
NADPH oxidase and Nrf2 regulate gastric aspiration-induced inflammation and acute lung injuryBruce A Davidson, R Robert Vethanayagam, Melissa J Grimm, et al.
Cancer Research|February 21, 2006
Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazoleMelinda S Yates, Mi-Kyoung Kwak, Patricia A Egner, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 2008
Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in miceThomas E Sussan, Tirumalai Rangasamy, David J Blake, et al.
Cancer Research|August 15, 2008
A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxinKaren Liby, Mark M Yore, Bill D Roebuck, et al.
Blood|August 3, 2007
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alphaSteffen Koschmieder, Francesco D'Alò, Hanna Radomska, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Biochemical and Biophysical Research Communications|January 22, 2008
A dicyanotriterpenoid induces cytoprotective enzymes and reduces multiplicity of skin tumors in UV-irradiated miceAlbena T Dinkova-Kostova, Stephanie N Jenkins, Scott L Wehage, et al.
Antioxidants & Redox Signaling|July 4, 2012
Targeting Nrf2-mediated gene transcription by extremely potent synthetic triterpenoids attenuate dopaminergic neurotoxicity in the MPTP mouse model of Parkinson's diseaseNavneet Ammal Kaidery, Rebecca Banerjee, Lichuan Yang, et al.
Molecular Cancer Therapeutics|January 24, 2007
Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genesMelinda S Yates, Masafumi Tauchi, Fumiki Katsuoka, et al.
Blood|January 5, 2002
Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemiaMarina Konopleva, Twee Tsao, Peter Ruvolo, et al.
Carcinogenesis|April 24, 2009
Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated miceMelinda S Yates, Quynh T Tran, Patrick M Dolan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 9, 2013
NADPH oxidase and Nrf2 regulate gastric aspiration-induced inflammation and acute lung injuryBruce A Davidson, R Robert Vethanayagam, Melissa J Grimm, et al.
Cancer Research|February 21, 2006
Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazoleMelinda S Yates, Mi-Kyoung Kwak, Patricia A Egner, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 2008
Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in miceThomas E Sussan, Tirumalai Rangasamy, David J Blake, et al.
Cancer Research|August 15, 2008
A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxinKaren Liby, Mark M Yore, Bill D Roebuck, et al.
Blood|August 3, 2007
CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alphaSteffen Koschmieder, Francesco D'Alò, Hanna Radomska, et al.
Pageof 12